RIVERSIDE, Calif. — A survey of U.S. multiple sclerosis, or MS, specialist clinicians reveals the COVID-19 pandemic has created major changes in how they deliver care.
“Since the pandemic began, more than 95% of our survey respondents reported using telehealth platforms to provide care for their patients,” said Dr. Elizabeth Morrison-Banks, a health sciences clinical professor of neurology in the School of Medicine at the University of California, Riverside, who led the survey reported in the journal Multiple Sclerosis and Related Disorders. “Approximately one half of the respondents were MS specialist neurologists, four out of five of whom indicated that COVID-19 had changed how they were recommending and prescribing MS disease-modifying therapies.”
During the pandemic, the MS specialist neurologists tended to prescribe fewer immunosuppressive agents.
Tech Update
Facebook invests in audio with short-form Soundbites feature, podcast support and a Clubhouse clone
Pandemic led to profound changes in multiple sclerosis clinical practice
Apex Legends is coming to Android and iOS
Expertise Is Failing To Create Clear Supply Chains
Once VMware is free from Dell, who might fancy buying it?
USU researchers develop power converter for long-distance, underwater electric grids
OnePlus Warp Charge 65 review: How to do proprietary charging in 2021